Prognostic Value of EndoPredict in Women with Hormone Receptor–Positive, HER2-Negative Invasive Lobular Breast Cancer-Reference-Cited by-同舟云学术

Prognostic Value of EndoPredict in Women with Hormone Receptor–Positive, HER2-Negative Invasive Lobular Breast Cancer

Published:2020-06-19 Issue:17 Volume:26 Page:4682-4687
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Sestak Ivana,Filipits Martin^ORCID,Buus Richard^ORCID,Rudas Margaretha,Balic Marija^ORCID,Knauer Michael,Kronenwett Ralf,Fitzal Florian,Cuzick Jack^ORCID,Gnant Michael^ORCID,Greil Richard,Dowsett Mitch,Dubsky Peter

Funder

Cancer Research UK

Royal Marsden

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomograms to predict the long-term prognosis for non-metastatic invasive lobular breast carcinoma: a population-based study;Scientific Reports;2024-08-22

2. Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trials;JNCI: Journal of the National Cancer Institute;2024-08-10

3. Selecting postoperative adjuvant systemic therapy for early‐stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays;Journal of Surgical Oncology;2024-06-24

4. The Challenges of Lobular Carcinomas from a Surgeon’s Point of View;Clinical Breast Cancer;2024-06

5. Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial;ESMO Open;2024-05